PURE BIOSCIENCE, INC. (PURE)
SEC fundamentals · as filed in 10-Q FY2026, period ended Apr 30, 2026 · updated Oct 7, 2026
as filed in 10-Q FY2026, period ended Apr 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Apr 30, 2026, PURE BIOSCIENCE, INC. reported revenue of $506,000, net income of -$624,000, and total assets of $1.6M. Every figure below is taken directly from PURE BIOSCIENCE, INC.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2016–FY2025 · as reported
- FY2016 revenue
- $1.3M
- FY2025 revenue
- $2.2M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $2.2M | -$2.4M |
| FY2024 | $2.0M | -$3.4M |
| FY2023 | $1.9M | -$4.0M |
| FY2022 | $1.9M | -$3.5M |
| FY2021 | $3.9M | -$2.3M |
| FY2020 | $6.9M | $4,000 |
| FY2019 | $1.9M | -$6.6M |
| FY2018 | $1.8M | -$7.4M |
| FY2017 | $1.8M | -$6.3M |
| FY2016 | $1.3M | -$14.4M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Oct 29, 2026 | on EDGAR ↗ |
| 8-K | Oct 20, 2026 | on EDGAR ↗ |
| 8-K | Jun 15, 2026 | on EDGAR ↗ |
| 10-Q | Jun 15, 2026 | on EDGAR ↗ |
| 8-K | May 5, 2026 | on EDGAR ↗ |
| 8-K | Mar 17, 2026 | on EDGAR ↗ |
| 10-Q | Mar 17, 2026 | on EDGAR ↗ |
| 8-K | Feb 20, 2026 | on EDGAR ↗ |
| DEF 14A | Dec 30, 2025 | on EDGAR ↗ |
| 8-K | Dec 15, 2025 | on EDGAR ↗ |
Balance Sheet
as of Apr 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Apr 30, 2026
| Revenue | $506,000 | Revenue | source ↗ |
| Net Income | -$624,000 | Net | source ↗ |
| Operating Income | -$518,000 | Operating | source ↗ |
| Gross Profit | $269,000 | Gross | source ↗ |
| Cost of Revenue | $237,000 | Cost | source ↗ |
| R&D Expense | $79,000 | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Apr 30, 2026
| EPS (diluted) | $-0.01 | Earnings | source ↗ |
| EPS (basic) | $-0.01 | Earnings | source ↗ |
| Shares Outstanding | 130.0M | Entity | source ↗ |
| Cash from Operations | -$468,000 | Net | source ↗ |
| Cash from Financing | $1.3M | Net | source ↗ |
| Cash from Investing | — | — | source ↗ |
Restatement history
Point-in-time3 of 400 annual fact-keys were materially restated between filings: what PURE BIOSCIENCE, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches PURE’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/PURE
MCP tool:
get_sec_fundamentals ticker=PURE - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/PURE/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=PURE as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/PURE/history
MCP tool:
get_fundamentals_history ticker=PURE - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/PURE
MCP tool:
get_financial_health ticker=PURE
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.